Vimarsana
Biggest News Aggregation in the World

Development Ncbi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development Ncbi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development Ncbi Today - Breaking & Trending Today

AROBS enters the Polish market by acquiring SYDERAL Polska - Vimarsana News

AROBS enters the Polish market by acquiring SYDERAL Polska

/PRNewswire/ -- AROBS Transilvania Software, the largest technology company listed on the Bucharest Stock Exchange, acquired the majority stake, of 94%, in...

AROBS Transilvania Software: AROBS enters the Polish market by acquiring SYDERAL Polska - Vimarsana News

AROBS Transilvania Software: AROBS enters the Polish market by acquiring SYDERAL Polska

CLUJ-NAPOCA, Romania, Feb. 2, 2023 /PRNewswire/ -- AROBS Transilvania Software, the largest technology company listed on the Bucharest Stock Exchange, acquired the majority stake, of 94%, in

Record-High Revenue And One Of The Highest Net Profits Ever: GPW Group In 2021 - Vimarsana News

Record-High Revenue And One Of The Highest Net Profits Ever: GPW Group In 2021

<ul> <li><b>Record-high sales revenue of PLN 407.6 million</b></li> <li><b>EBITDA of PLN 215.2 million</b></li> <li><b>Net profit of PLN 161.3 million</b></li> <li><b>Increase of operating expenses by 11.3% to PLN 229.4 million</b></li> <li><b>Cost/income (C/I) ratio at 56.3% in 2021</b></li> <li><b>Dividend payment of PLN 104.9 million (i.e. PLN 2.50 per share)</b></li> <li><...

Ryvu Therapeutics Reports First Quarter 2021 Financial Results - Vimarsana News

Ryvu Therapeutics Reports First Quarter 2021 Financial Results

Ryvu Therapeutics Reports First Quarter 2021 Financial Results News provided by Share this article Share this article KRAKOW, Poland, May 12, 2021 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU) reported today its first quarter 2021 financial results and provided a corporate update. "Q1 2021 was an eventful quarter for Ryvu and developments around RVU120 played a key role in it" - commented Pawel Przewiezlikowski, Chief Executive Officer of Ryvu. "We have submitted a clinical trial application to conduct a Phase I/II study of RVU120 in patients with solid tumors, and shortly after that we receiv...

Solaris Bus in Polish second-life battery consortium - Vimarsana News

Solaris Bus in Polish second-life battery consortium

Solaris Bus in Polish second-life battery consortium A consortium comprising Solaris Bus & Coach, Impact Clean Power Technology S.A. and TAURON Polska Energia will implement a project titled “Second Life ESS” with the aim to create a prototype system to store electric energy based on retired electric bus batteries. The project is being co-financed by the National Center for Research and Development (NCBiR) in Poland. Solaris launched its first electric bus back in 2011. Since then, the manufacturer has sold more than 1,000 e-buses to several dozen towns and cities across 18 countries. The...